Upon administration, GnRH agonists cause a temporary surge in the production of LH and FSH, which increases sex hormone levels. However, with continuous use, they desensitize the GnRH receptors in the pituitary gland. This desensitization results in decreased secretion of LH and FSH, leading to a significant reduction in ovarian hormone production, particularly estrogen.
